مواد پر جائیں
ابھی

جاری ہےدن 1

NSW September unauthorized-peptide emergency visits

  1. اپ ڈیٹ 1 از 1تازہ تریندن 1

    NSW records 1,180 peptide-linked emergency visits amid warnings on online products

    Fifteen months of NSW surveillance show a sharp rise in emergency presentations associated with peptide use. The warning concerns unapproved products—not every peptide medicine.

    دیکھیں

    سب سے پہلا ماخذABC listen

    ہمیں پہلے کیا معلوم تھا

    • 1,180Emergency presentations over fifteen months
    • 5Presentations in July 2025
    • More than 217Presentations in September 2026
    • NSW recorded a sharp rise in emergency presentations associated with peptide use, alongside a ministerial warning about serious harm from unregulated products.

    تب تک حل طلب

    • The surveillance does not identify the products involved, their verified contents, the number of distinct patients or how many suffered lasting injury.

    جس پر نظر رکھنے کا ہم نے کہا تھا

    • Product-specific findings, fuller surveillance definitions and patient outcomes would show more clearly what is driving the increase. No date has been announced for the next surveillance release.

کس نے رپورٹ کیا

کس نے رپورٹ کیا

11 ذرائع ابلاغ · 25 ماخذ · 1 ویڈیو

اس وقت تک 11 میں سے 4 رپورٹ کر چکے تھے

کون شامل ہے

کون شامل ہے

تنظیمیں

  • Ministry of Healthministry in New South Wales, Australia
  • Therapeutic Goods Administrationregulatory body for therapeutic goods (including medicines, medical devices, gene technology, and blood products) in Australia

مقامات

  • New South Wales